Covid-19 Vaccination is available to Americans aged 12 and up, but younger children must wait. Pharmaceutical companies Pfizer and Moderna are still doing clinical trials to assess how coronavirus vaccines function in children under 12 — if they’re safe-and the optimum dose.
Meanwhile, all but four states are witnessing an uptick in instances, with doctors describing younger and sicker patients than those seen in the winter. Because of the increase in instances, many parents of children under 12 wonder when their little and not-so-little ones will obtain the vaccine.
Data for children aged 2 to 5 years old could be available soon. Pfizer said it might have data on the youngest youngsters in October or November and ask the FDA to approve e-cigarettes soon. However, because the FDA’s emergency use considerations can take several weeks, a vaccine for younger children is unlikely to be accessible until late this fall or even next year. About 6,700 youngsters aged six months to 11 years are being enrolled in Moderna’s Vaccination research. It refused to provide CNN a time frame for when it may get trial data results.